This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignees: Pfizer Corporation, University of California, Leland Stanford Junior University. Active years: 2018-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
7 out of 4,488 
4 out of 16,025 
3 out of 5,512 
Years Active: 2018-2026
Title: Innovator in Immunology: Natasha K Crellin
Introduction
Natasha K Crellin is a distinguished inventor based in San Carlos, California. She has made significant contributions to the field of immunology through her innovative research and inventions, holding a total of six patents. Her work focuses on advancing treatments for immune diseases, disorders, and cancer, showcasing her dedication to improving patient outcomes.
Latest Patents
Natasha's latest patents include:
1. Lymphocyte function-associated antigen 3 (LFA3) variant polypeptides and methods of use thereof to treat CD2-mediated immune diseases, disorders or conditions. This invention provides LFA3 polypeptide molecules, specifically variant LFA3 fusion polypeptide molecules, along with methods for their application.
2. BTLA fusion protein agonists and uses thereof. This patent highlights a significant discovery concerning BTLA agonist fusion proteins that enhance immune responses. It provides fusion proteins that bind BTLA, improving BTLA signaling and offering methods for treating cancer and various immune and inflammatory diseases.
Career Highlights
Natasha K Crellin has worked with notable organizations such as Pfizer Corporation and the University of California. Her roles in these reputable institutions have allowed her to collaborate with fellow innovators and contribute to groundbreaking research in immunology.
Collaborations
Throughout her career, Natasha has collaborated with esteemed colleagues, including Eleonora Trotta and Jeffrey A Bluestone. These partnerships have enriched her research endeavors and have been instrumental in her innovative approaches to treating complex immune-related conditions.
Conclusion
Natasha K Crellin is a prominent figure in the field of immunology, recognized for her innovative patents and research contributions. Her dedication to addressing immune diseases and her collaborative spirit exemplify the essence of modern scientific discovery. Through her work, she continues to pave the way for new therapeutic avenues, impacting the lives of many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile